Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade
KDB
Efficacy and Safety of the ab Interno Trabeculectomy With Kahook Dual Blade Combined With Cataract Surgery Versus Cataract Surgery Alone: a Prospective, Single-center, Randomized Study
1 other identifier
interventional
42
1 country
1
Brief Summary
The Kahook Dual Blade is a single-use device specially designed to create a clean cut in the trabecular meshwork. This ablation in the trabecular meshwork allows a better outflow of the aqueous humor, thus reducing the intraocular pressure (IOP), theoretically beyond the IOP reduction achieved by other minimally invasive glaucoma surgery (MIGS) devices. Studies already published showed good results in terms of the reduction of the number of glaucoma medications and the reduction in the IOP, but not a single study has been performed prospectively comparing the efficacy of the technique, not even with the cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2018
CompletedFirst Submitted
Initial submission to the registry
December 15, 2019
CompletedFirst Posted
Study publicly available on registry
December 17, 2019
CompletedDecember 20, 2019
December 1, 2019
10 months
December 15, 2019
December 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Evolution during follow up of the intraocular pressure
in mmHg
Up to 12 months
Reduction in number of glaucoma medications
Difference between number of glaucoma medications before and after the treatment
Up to 12 months
Secondary Outcomes (5)
Increase in visual acuity
Up to 12 months
Rate of reduction in endothelial cell count
Up to 12 months
Increase of corneal astigmatism
Up to 12 months
Rate of visual field progression
Up to 12 months
Proportion of patients achieving the success endpoint
Up to 12 months
Study Arms (2)
Combined surgery
EXPERIMENTALParticipants intervened of combined ab interno trabeculectomy and cataract surgery at the same time
Cataract surgery
ACTIVE COMPARATORParticipants intervened of cataract surgery alone
Interventions
Ab interno trabeculectomy performed after pupil contraction and 90 degrees ablation of the nasal trabecular meshwork
Cataract surgery with minimal clear cornea incision and phacoemulsification
Eligibility Criteria
You may qualify if:
- Participants aged 18 - 85 years
- Full comprehension and signing of the informed consent
- Preoperative intraocular pressure below 24 mmHg and at least one glaucoma medication
- Previous diagnose of open-angle glaucoma or ocular hypertension, including pseudoexfoliative glaucoma or pigment dispersion syndrome
- Mild to moderate glaucoma, according to the Hodapp-Parrish-Anderson classification
You may not qualify if:
- Not signing of the informed consent
- Not being able to attend to all the follow-up visits
- Young females during pregnancy or lactation
- Any other form of glaucoma not previously mentioned
- Glaucoma secondary to elevated episcleral venous pressure
- Preoperative best-corrected visual acuity lower than 0.1
- Clear lens extraction
- Severe or end-stage glaucoma
- Previous glaucoma surgery, cataract surgery or retinal surgery
- Patients taking anticoagulant medication that could not be discontinued during the perioperative period
- Oral anhydrase carbonic inhibitors
- Severe or uncontrolled systemic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital San Carlos
Madrid, 28040, Spain
Related Publications (3)
Greenwood MD, Seibold LK, Radcliffe NM, Dorairaj SK, Aref AA, Roman JJ, Lazcano-Gomez GS, Darlington JK, Abdullah S, Jasek MC, Bahjri KA, Berdahl JP. Goniotomy with a single-use dual blade: Short-term results. J Cataract Refract Surg. 2017 Sep;43(9):1197-1201. doi: 10.1016/j.jcrs.2017.06.046.
PMID: 28991617BACKGROUNDDorairaj SK, Seibold LK, Radcliffe NM, Aref AA, Jimenez-Roman J, Lazcano-Gomez GS, Darlington JK, Mansouri K, Berdahl JP. 12-Month Outcomes of Goniotomy Performed Using the Kahook Dual Blade Combined with Cataract Surgery in Eyes with Medically Treated Glaucoma. Adv Ther. 2018 Sep;35(9):1460-1469. doi: 10.1007/s12325-018-0755-4. Epub 2018 Aug 4.
PMID: 30078175BACKGROUNDVentura-Abreu N, Garcia-Feijoo J, Pazos M, Biarnes M, Morales-Fernandez L, Martinez-de-la-Casa JM. Twelve-month results of ab interno trabeculectomy with Kahook Dual Blade: an interventional, randomized, controlled clinical study. Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2771-2781. doi: 10.1007/s00417-021-05213-0. Epub 2021 Apr 27.
PMID: 33907888DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Julian Garcia Feijoo, Professor
Hospital San Carlos
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
December 15, 2019
First Posted
December 17, 2019
Study Start
February 2, 2017
Primary Completion
November 29, 2017
Study Completion
November 30, 2018
Last Updated
December 20, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will only be shared if other investigators in their respective centers perform the clinical trial in a similar fashion. Personal information will not ever be shared, and medical records would be shared according to the current legislation of the European Union